This study tests a drug called bezisterim (NE3107) in 60 people with early Parkinson's disease who have not yet started standard treatment. Participants take the drug or a placebo twice daily for four months to see if it improves movement symptoms like stiffness and slowness. The…
Phase: PHASE2 • Sponsor: BioVie Inc. • Aim: Symptom relief
Last updated May 26, 2026 09:03 UTC